This Bishop McGuinness girls basketball star was named Conference Player of the Year for the fourth consecutive season.

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Announcing the passing of a loved one in local news media is a long standing tradition and we are proud of the trust placed ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipeline of new molecular entities (NMEs) has been culled in the last few months as part of a shift ...

From left: 'The Last of Us,' 'Your Friends and Neighbors,' 'Wednesday,' 'Percy Jackson and Olympians' and 'The Handmaid's Tale' Hulu/Apple/Netflix Following a packed year for television with two ...

"Cam, Don and the hockey operations team have my full support as they make these very difficult decisions." The post Bruins CEO Charlie Jacobs gives Cam Neely, Don Sweeney ‘full support’ after Brad ...